Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide, with age being a significant risk factor for the development and progression of these conditions. As individuals age, their risk of developing CVD increases due to various physiological changes in the cardiovascular system. DNA methylation age acceleration, which refers to the discrepancy between an individual's chronological age and their biological age, has been shown to play a role in the pathogenesis of CVD. CD BioSciences helps clients conduct association studies of DNA methylation age acceleration and cardiovascular diseases to investigate the relationship between aging and cardiovascular health.
At CD BioSciences, we assist our clients in conducting association studies to investigate the relationship between DNA methylation age acceleration and different types of cardiovascular diseases. Some of the CVDs that we analyze include:
At CD BioSciences, our tireless efforts and expertise in researching the association between accelerated age and cardiovascular disease enable us to provide high-quality and comprehensive services. Upon completion of our association study, our clients can expect to receive a comprehensive report. Our deliverables are tailored and designed to provide reliable and meaningful insights. If you are interested in our services, please feel free to contact us or make an online inquiry.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.